ANI Pharmaceuticals
ANIP
68.55
-0.58
-0.84%
ANI Pharmaceuticals
US · ANIP
#2919 by market cap
Listed 1970
68.55
-0.58
-0.84%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:01
Quant vs Street three independent views, side by side
StockVane factor grade
A
Momentum strategy signal
Sell
Analyst consensus
Buy
Mostly aligned, one view stands apart.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Analyst consensus 7 analysts
Buy
Avg price target 105.14 +53.4%
Price target rangecurrent 68.55
Low85.00
Avg105.14
High121.00
Buy 71%
Hold 29%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-11-06 | CCORF | -- | Hold | 90.00 |
| 2026-11-06 | H.C. Wainwright | -- | Buy | 121.00 |
| 2026-11-05 | Guggenheim | -- | Buy | 121.00 |
| 2026-10-22 | J.P. Morgan | -- | Buy | 115.00 |
| 2026-10-05 | Guggenheim | -- | Buy | 119.00 |
| 2026-09-23 | Oppenheimer | -- | Hold | 85.00 |
| 2026-09-21 | H.C. Wainwright | -- | Buy | 121.00 |
| 2026-09-09 | Leerink Partners | -- | Buy | 104.00 |
| 2026-08-25 | Barclays | -- | Buy | 100.00 |
| 2026-08-11 | H.C. Wainwright | -- | Buy | 121.00 |
| 2026-08-10 | CCORF | -- | Hold | 90.00 |
| 2026-08-10 | J.P. Morgan | -- | Buy | 115.00 |
| 2026-08-07 | Guggenheim | -- | Buy | 119.00 |
| 2026-08-05 | Barclays | -- | Buy | 100.00 |
| 2026-07-17 | CCORF | -- | Hold | 91.00 |
| 2026-07-16 | CCORF | -- | Hold | 91.00 |
| 2026-07-14 | Guggenheim | -- | Buy | 124.00 |
| 2026-07-13 | H.C. Wainwright | -- | Buy | 121.00 |
| 2026-07-09 | Guggenheim | -- | Buy | 124.00 |
| 2026-05-20 | Barclays | -- | Buy | 100.00 |
| 2026-05-11 | Truist Financial | -- | Hold | -- |
| 2026-05-10 | Guggenheim | -- | Buy | 124.00 |
| 2026-05-08 | H.C. Wainwright | -- | Buy | 121.00 |
| 2026-04-23 | Piper Sandler | -- | Buy | 111.00 |
| 2026-04-16 | Guggenheim | -- | Buy | 124.00 |
Price target trend monthly average, last 3 years
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q3 | 2026-11-05 | -- | ±8.76% | -2.83% (in line) |
| 2026/Q2 | 2026-08-07 | -- | ±9.98% | -5.30% (in line) |
| 2026/Q1 | 2026-05-08 | -- | ±8.03% | -2.44% (in line) |
| 2025/Q4 | 2026-02-27 | -- | ±12.21% | -4.21% (in line) |
| 2025/Q3 | 2025-11-07 | -- | ±8.17% | +0.22% (in line) |
| 2025/Q2 | 2025-08-08 | -- | ±12.06% | +18.07% (beat) |
| 2025/Q1 | 2025-05-09 | -- | ±12.57% | -7.31% (in line) |
| 2024/Q4 | 2025-02-28 | -- | ±15.48% | +13.39% (in line) |
| 2024/Q3 | 2024-11-08 | -- | ±10.99% | +5.24% (in line) |
| 2024/Q2 | 2024-08-06 | -- | ±11.66% | +6.98% (in line) |
| 2024/Q1 | 2024-05-10 | -- | ±7.89% | +3.29% (in line) |
| 2023/Q4 | 2024-02-29 | -- | ±10.51% | +12.26% (beat) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-11-20 20:01:05 · For reference only, not investment advice and not tailored to your situation.
ANI Pharmaceuticals discussion 0 comments